Peptide Library

FDA-approved

Digestive & weight

Teduglutide

Evidence

FDA approved

Class

GLP-2 receptor agonist

/

Teduglutide

KEY TAKEAWAY

Teduglutide is a modified version of GLP-2, a gut hormone that supports growth of the intestinal lining. It is sold as Gattex. The FDA approved teduglutide (Gattex) in 2012 for adults with short bowel syndrome, and later for children.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

GLP-2 receptor agonist

Approved for

Short bowel syndrome that depends on intravenous nutrition

Key fact

The FDA approved teduglutide (Gattex) in 2012 for adults with short bowel syndrome, and later for children.

Route

Daily subcutaneous injection

Evidence strength

FDA approved

What it is

What it is

Teduglutide is a modified version of GLP-2, a gut hormone that supports growth of the intestinal lining. It is sold as Gattex.

How it works

How it works

It activates GLP-2 receptors, which increases absorption of fluid and nutrients by helping the intestinal lining grow.

Regulatory status

Regulatory status

The FDA approved teduglutide (Gattex) in 2012 for adults with short bowel syndrome, and later for children.

What it is used for

What it is used for

Short bowel syndrome that depends on intravenous nutrition.

Side effects and risks

Side effects and risks

Abdominal pain, swelling and nausea are common. Because it promotes growth of the gut lining, it can enlarge polyps, so colonoscopy monitoring is needed.

Citations

Citations

U.S. FDA prescribing information for Teduglutide. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo